<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01136330</url>
  </required_header>
  <id_info>
    <org_study_id>AFM-13286</org_study_id>
    <nct_id>NCT01136330</nct_id>
  </id_info>
  <brief_title>DM1 Heart Registry - DM1 Respiratory Registry</brief_title>
  <acronym>DM1-Heart-R</acronym>
  <official_title>Cardiac and Respiratory Prognostic Factors in Patients With Myotonic Dystrophy Type 1</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut de Myologie, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut de Myologie, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Myotonic dystrophy type 1 (DM1) is the most frequent neuromuscular disease in adults. DM1
      patients have an impaired prognosis (mean age of death &lt;60 years) due to cardiac and
      respiratory complications.

      Our primary objective was to identify cardiac and respiratory prognostic factors in DM1.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. Patients with genetically proven DM1 who were admitted in Pitié Salpêtrière Hospital
           from 2000 and 2010 will be identified. These patients systematically underwent
           neurological, cardiac and respiratory investigations.

        2. Baseline medical and genetic information will be entered in a dedicated database,
           including cardiac and respiratory investigations.

        3. The occurence of severe cardiac and respiratory adverse events will also be collected.

        4. Statistical analysis will be performed to look for correlations between baseline patient
           characteristics and cardiac or respiratory adverse events during follow up.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2010</start_date>
  <completion_date type="Actual">September 2011</completion_date>
  <primary_completion_date type="Actual">September 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <enrollment type="Actual">914</enrollment>
  <condition>Myotonic Dystrophy</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Myotonic dystrophy type 1
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  DM1 mutation (&gt;50 CTG repeats)

          -  Age &gt; 18 years

        Exclusion Criteria:

          -  Patient refusal
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Denis Duboc, MD,PhD</last_name>
    <role>Study Director</role>
    <affiliation>APHP</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Pitié Salpêtrière Hospital</name>
      <address>
        <city>Paris</city>
        <state>Ile de France</state>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 2, 2010</study_first_submitted>
  <study_first_submitted_qc>June 2, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 3, 2010</study_first_posted>
  <last_update_submitted>February 17, 2012</last_update_submitted>
  <last_update_submitted_qc>February 17, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 20, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Institut de Myologie, France</investigator_affiliation>
    <investigator_full_name>Karim WAHBI</investigator_full_name>
    <investigator_title>Karim WAHBI MD,PHD.</investigator_title>
  </responsible_party>
  <keyword>Myotonic dystrophy</keyword>
  <keyword>Prognosis</keyword>
  <keyword>Sudden death</keyword>
  <keyword>Respiratory failure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myotonic Dystrophy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

